NGP Capital

NGP Capital is an active, partner-owned venture capital firm focused on early- and growth-stage B2B technology companies rather than a drug-development or healthcare operating company. Founded in 2005 as Nokia Growth Partners and rebranded to NGP Capital in 2017, the firm invests across themes such as cybersecurity, edge cloud, digital industry, data infrastructure, and broader digital transformation. Nokia is its sole limited partner for at least its Fund V vehicle, but NGP Capital describes itself as an independent venture firm. The firm has offices across North America, Europe, and Asia and has also published and invested selectively in digital health, though healthcare is not its primary operating focus. For a biotech analyst, the key takeaway is that NGP Capital is best categorized as a technology VC investor with some historical exposure to digital health portfolio companies, not as a biotech, pharma, CRO, CMO, or therapeutic developer.